Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.

Oncology reports - 1 Mar 2010

Tanuma Jun-Ichi, Izumo Toshiyuki, Hirano Masato, Oyazato Yoshitaka, Hori Fumiya, Umemura Eri, Shisa Hayase, Hiai Hiroshi, Kitano Motoo

Abstract excerpt

The genotype of the fibroblast growth factor receptor 4 (FGFR4) gene and TP53 mutation have been reported as prognostic factors for cancers of the head and neck, bladder, breast and colon. To determine whether they are applicable for oral squamous cell carcinoma (OSCC), we investigated these two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Mouth Neoplasms

Share to Polymorphism, Genetic

Share to Prognosis

Share to Receptor, Fibroblast Growth Factor, Type 4

Source

Identifiers

PMID: 20127014

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20127014-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.PMID 20127014Read ↗

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis.Semantic proximity Read ↗

Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.Semantic proximity Read ↗

FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma.Semantic proximity Read ↗

FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.Semantic proximity Read ↗

The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.Semantic proximity Read ↗

Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma PatientsSemantic proximity Read ↗

ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.Semantic proximity Read ↗

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.